• Je něco špatně v tomto záznamu ?

High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins

MR. Tavares, M. Bláhová, L. Sedláková, L. Elling, H. Pelantová, R. Konefał, T. Etrych, V. Křen, P. Bojarová, P. Chytil

. 2020 ; 21 (2) : 641-652. [pub] 20200123

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020750

N-Acetyllactosamine (LacNAc; Galβ4GlcNAc) is a typical disaccharide ligand of galectins. The most abundant members of these human lectins, galectin-1 (Gal-1) and galectin-3 (Gal-3), participate in a number of pathologies including cancerogenesis and metastatic formation. In this study, we synthesized a series of fifteen N-(2-hydroxypropyl)methacrylamide (HPMA)-based glycopolymers with varying LacNAc amounts and presentations and evaluated the impact of their architecture on the binding affinity to Gal-1 and Gal-3. The controlled radical reversible addition-fragmentation chain transfer copolymerization technique afforded linear polymer precursors with comparable molecular weight (Mn ≈ 22,000 g mol-1) and narrow dispersity (D̵ ≈ 1.1). The precursors were conjugated with the functionalized LacNAc disaccharide (4-22 mol % content in glycopolymer) prepared by enzymatic synthesis under catalysis by β-galactosidase from Bacillus circulans. The structure-affinity relationship study based on the enzyme-linked immunosorbent assay revealed that the type of LacNAc presentation, individual or clustered on bi- or trivalent linkers, brings a clear discrimination (almost 300-fold) between Gal-1 and Gal-3, reaching avidity to Gal-1 in the nanomolar range. Whereas Gal-1 strongly preferred a dense presentation of individually distributed LacNAc epitopes, Gal-3 preferred a clustered LacNAc presentation. Such a strong galectin preference based just on the structure of a multivalent glycopolymer type is exceptional. The prepared nontoxic, nonimmunogenic, and biocompatible glycopolymers are prospective for therapeutic applications requiring selectivity for one particular galectin.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020750
003      
CZ-PrNML
005      
20210830102409.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.biomac.9b01370 $2 doi
035    __
$a (PubMed)31904940
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tavares, Marina Rodrigues $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
245    10
$a High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins / $c MR. Tavares, M. Bláhová, L. Sedláková, L. Elling, H. Pelantová, R. Konefał, T. Etrych, V. Křen, P. Bojarová, P. Chytil
520    9_
$a N-Acetyllactosamine (LacNAc; Galβ4GlcNAc) is a typical disaccharide ligand of galectins. The most abundant members of these human lectins, galectin-1 (Gal-1) and galectin-3 (Gal-3), participate in a number of pathologies including cancerogenesis and metastatic formation. In this study, we synthesized a series of fifteen N-(2-hydroxypropyl)methacrylamide (HPMA)-based glycopolymers with varying LacNAc amounts and presentations and evaluated the impact of their architecture on the binding affinity to Gal-1 and Gal-3. The controlled radical reversible addition-fragmentation chain transfer copolymerization technique afforded linear polymer precursors with comparable molecular weight (Mn ≈ 22,000 g mol-1) and narrow dispersity (D̵ ≈ 1.1). The precursors were conjugated with the functionalized LacNAc disaccharide (4-22 mol % content in glycopolymer) prepared by enzymatic synthesis under catalysis by β-galactosidase from Bacillus circulans. The structure-affinity relationship study based on the enzyme-linked immunosorbent assay revealed that the type of LacNAc presentation, individual or clustered on bi- or trivalent linkers, brings a clear discrimination (almost 300-fold) between Gal-1 and Gal-3, reaching avidity to Gal-1 in the nanomolar range. Whereas Gal-1 strongly preferred a dense presentation of individually distributed LacNAc epitopes, Gal-3 preferred a clustered LacNAc presentation. Such a strong galectin preference based just on the structure of a multivalent glycopolymer type is exceptional. The prepared nontoxic, nonimmunogenic, and biocompatible glycopolymers are prospective for therapeutic applications requiring selectivity for one particular galectin.
650    _2
$a akrylamidy $x chemie $7 D000178
650    _2
$a aminocukry $x chemie $7 D000606
650    _2
$a Bacillus $x enzymologie $7 D001407
650    _2
$a krevní proteiny $x analýza $x metabolismus $7 D001798
650    _2
$a katalýza $7 D002384
650    _2
$a disacharidy $x chemická syntéza $7 D004187
650    _2
$a ELISA $7 D004797
650    _2
$a epitopy $7 D000939
650    _2
$a galektin 1 $x analýza $x metabolismus $7 D037483
650    _2
$a galektiny $x analýza $x metabolismus $7 D037161
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a polymerizace $7 D058105
650    _2
$a polymery $x chemie $x metabolismus $x farmakologie $7 D011108
650    _2
$a beta-galaktosidasa $x metabolismus $7 D001616
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bláhová, Markéta $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
700    1_
$a Sedláková, Lieselotte $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering , Czech Technical University in Prague , Sítná sq. 3105 , CZ-272 01 Kladno , Czech Republic
700    1_
$a Elling, Lothar $u Institute of Biotechnology and Helmholtz Institute for Biomedical Engineering , RWTH Aachen , Pauwelstr. 20 , D-52079 Aachen , Germany
700    1_
$a Pelantová, Helena $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic
700    1_
$a Konefał, Rafał $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
700    1_
$a Etrych, Tomáš $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
700    1_
$a Křen, Vladimír $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic
700    1_
$a Bojarová, Pavla $u Institute of Microbiology , Czech Academy of Sciences , Vídeňská 1083 , CZ-142 20 Prague 4 , Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering , Czech Technical University in Prague , Sítná sq. 3105 , CZ-272 01 Kladno , Czech Republic
700    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry , Czech Academy of Sciences , Heyrovského náměstí 2 , CZ-162 06 Prague 6 , Czech Republic
773    0_
$w MED00006456 $t Biomacromolecules $x 1526-4602 $g Roč. 21, č. 2 (2020), s. 641-652
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31904940 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102409 $b ABA008
999    __
$a ok $b bmc $g 1691344 $s 1141196
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 2 $d 641-652 $e 20200123 $i 1526-4602 $m Biomacromolecules $n Biomacromolecules $x MED00006456
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...